Cell BioEngines

About:

Allogeneic 'Off-the-Shelf' Cell-based Therapies

Website: https://cellbioengines.com/

Twitter/X: cell_bioengines

Top Investors: SOSV, Harvard Innovation Labs, New York Ventures

Description:

Cell BioEngines, Inc., is a clinical-stage biotech company focused on developing allogeneic 'off-the-shelf' stem cell and its derived therapies as ‘drugs’ for human disease treatment. The company has a ‘plug-and-play’ blood stem cell-derived epigenetic platform, to address donor source availability, cellular potency, and scaling complexities in manufacturing clinical grade cell products.

Total Funding Amount:

$1.38M

Headquarters Location:

New York, New York, United States

Founded Date:

2022-12-22

Contact Email:

info(AT)cellbioengines.com

Founders:

Ajay Vishwakarma, Alexey Bersenev

Number of Employees:

1-10

Last Funding Date:

2024-07-23

IPO Status:

Private

Industries:

© 2025 bioDAO.ai